BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24821382)

  • 21. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
    Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells.
    Tie X; Han S; Meng L; Wang Y; Wu A
    PLoS One; 2013; 8(6):e66008. PubMed ID: 23762456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells.
    Kaur G; Kim J; Kaur R; Tan I; Bloch O; Sun MZ; Safaee M; Oh MC; Sughrue M; Phillips J; Parsa AT
    J Clin Neurosci; 2013 Jul; 20(7):1014-8. PubMed ID: 23693024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells.
    Wang F; Yang L; Shi L; Li Q; Zhang G; Wu J; Zheng J; Jiao B
    Oncotarget; 2015 Aug; 6(25):21468-78. PubMed ID: 26056081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas.
    Wang H; Li P; Zhao B
    Gene; 2013 Oct; 528(2):146-53. PubMed ID: 23911301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic level changes associated with S3I201 treated U87 glioma cells.
    Jain R; Atak A; Yeola A; Srivastava S
    J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.
    Moutal A; Villa LS; Yeon SK; Householder KT; Park KD; Sirianni RW; Khanna R
    Mol Neurobiol; 2018 May; 55(5):4403-4416. PubMed ID: 28660485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.
    Põlajeva J; Bergström T; Edqvist PH; Lundequist A; Sjösten A; Nilsson G; Smits A; Bergqvist M; Pontén F; Westermark B; Pejler G; Forsberg Nilsson K; Tchougounova E
    Mol Oncol; 2014 Feb; 8(1):50-8. PubMed ID: 24091309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms of EGF regulation of COX-2 through the STAT5 signaling pathway in human lung adenocarcinoma A549 cells].
    Cao S; Zhao G; Dong Q; Han J; Xin Y; Yan Y; Li J; Cui J
    Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):169-76. PubMed ID: 23601296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas.
    Dubois N; Berendsen S; Tan K; Schoysmans L; Spliet W; Seute T; Bours V; Robe PA
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells.
    Wittig I; Groner B
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):449-63. PubMed ID: 16375697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR and EGFRvIII in glioblastoma: partners in crime.
    Zadeh G; Bhat KP; Aldape K
    Cancer Cell; 2013 Oct; 24(4):403-4. PubMed ID: 24135276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein complexes and target genes identification by in vivo biotinylation: the STAT5 paradigm.
    Katsantoni E
    Sci Signal; 2012 Oct; 5(248):pt13. PubMed ID: 23112345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 17
    Castracani CC; Longhitano L; Distefano A; Anfuso D; Kalampoka S; La Spina E; Astuto M; Avola R; Caruso M; Nicolosi D; Giallongo C; Tibullo D; Volti GL
    J Oncol; 2020; 2020():2314693. PubMed ID: 32148493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
    Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B
    Front Oncol; 2021; 11():726745. PubMed ID: 34540695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STATegra: Multi-Omics Data Integration - A Conceptual Scheme With a Bioinformatics Pipeline.
    Planell N; Lagani V; Sebastian-Leon P; van der Kloet F; Ewing E; Karathanasis N; Urdangarin A; Arozarena I; Jagodic M; Tsamardinos I; Tarazona S; Conesa A; Tegner J; Gomez-Cabrero D
    Front Genet; 2021; 12():620453. PubMed ID: 33747045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.
    Gutiérrez-Hoya A; Soto-Cruz I
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
    Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Abt A; Orrillo SJ; Lastra Y; De Simone E; Boutillon F; Goffin V; Seilicovich A; Pisera DA; Ferraris MJ; Candolfi M
    Sci Rep; 2019 Dec; 9(1):19578. PubMed ID: 31862900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.
    Xu W; Bi Y; Kong J; Zhang J; Wang B; Li K; Tian M; Pan X; Shi B; Gu J; Jiang H; Kong X; Li Z
    Oncotarget; 2016 Apr; 7(17):24752-65. PubMed ID: 27029073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.